SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-228529
Filing Date
2023-09-05
Accepted
2023-09-05 16:06:02
Documents
13
Period of Report
2023-08-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d436622d8k.htm   iXBRL 8-K 25071
2 EX-10.1 d436622dex101.htm EX-10.1 35751
  Complete submission text file 0001193125-23-228529.txt   192897

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bxrx-20230831.xsd EX-101.SCH 2844
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bxrx-20230831_lab.xml EX-101.LAB 17978
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bxrx-20230831_pre.xml EX-101.PRE 11254
7 EXTRACTED XBRL INSTANCE DOCUMENT d436622d8k_htm.xml XML 3367
Mailing Address 490 LAPP ROAD MALVERN PA 19355
Business Address 490 LAPP ROAD MALVERN PA 19355 484-395-2470
Baudax Bio, Inc. (Filer) CIK: 0001780097 (see all company filings)

IRS No.: 474639500 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39101 | Film No.: 231235750
SIC: 8090 Services-Misc Health & Allied Services, NEC